About Geoffrey

Dr. McDonough is CEO of NodThera, a clinical stage company developing oral inhibitors of NLRP3 for people living with cardiometabolic diseases. He previously served as President & Chief Executive Officer of Generation Bio (NASDAQ: GBIO), as President & CEO of Sobi, and spent a decade at Genzyme, holding senior roles including President of Genzyme Europe and Senior Vice President & General Manager of the global Lysosomal Storage Diseases business. He trained in internal medicine and pediatrics at Massachusetts General Hospital and Boston Children’s Hospital and earned his M.D. from Harvard Medical School.